Indications and Applications of Arterial Stents for Stroke Prevention in Atherosclerotic Intracranial Stenosis | springermedizin.de

Springer Medizin

nach oben

Current Cardiology Reports

Erschienen in:

01.01.2010

Indications and Applications of Arterial Stents for Stroke Prevention in Atherosclerotic Intracranial Stenosis

verfasst von: Jeremy D. Fields, Kenneth C. Liu, Stanley L. Barnwell, Wayne M. Clark, Helmi L. Lutsep

Erschienen in: Current Cardiology Reports | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Intracranial stenosis accounts for 8–10% of all ischemic strokes in North America, a frequency slightly less than that of extracranial carotid stenosis. Among patients presenting with transient ischemic attack or stroke due to intracranial stenosis, the risk of recurrent stroke in the first year after initial symptoms is about 14%. Those with high-risk features (recent stroke and severe stenosis) have up to a 23% rate of recurrent stroke in the year after their initial event. Angioplasty with stenting has emerged as a potential treatment strategy, particularly in high-risk patients, although evidence is currently limited to uncontrolled prospective trials and retrospective case series. In this article, we critically review the clinical results supporting the use of stenting and highlight some key considerations in the application of this technology, including patient selection, procedural management, technical issues, and risk factors for complications and in-stent restenosis.

Anzeige

1.

Sacco RL, Kargman DE, Gu Q, Zamanillo MC: Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 1995, 26:14–20.PubMed

2.

White H, Boden-Albala B, Wang C, et al.: Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation 2005, 111:1327–1331.CrossRefPubMed

3.

Wong LK: Global burden of intracranial atherosclerosis. Int J Stroke 2006, 1:158–159.CrossRefPubMed

4.

Kasner SE, Chimowitz MI, Lynn MJ, et al.: Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006, 113:555–563.CrossRefPubMed

5.

Grubb RL Jr, Derdeyn CP, Fritsch SM, et al.: Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA 1998, 280:1055–1060.CrossRefPubMed

6.

Caplan LR, Hennerici M: Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol 1998, 55:1475–1482.CrossRefPubMed

7.

Lee DK, Kim JS, Kwon SU, et al.: Lesion patterns and stroke mechanism in atherosclerotic middle cerebral artery disease: early diffusion-weighted imaging study. Stroke 2005, 36:2583–2588.CrossRefPubMed

8.

Kang SY, Kim JS: Anterior cerebral artery infarction: stroke mechanism and clinical-imaging study in 100 patients. Neurology 2008, 70:2386–2393.CrossRefPubMed

9.

Chimowitz MI, Lynn MJ, Howlett-Smith H, et al.: Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005, 352:1305–1316.CrossRefPubMed

10.

Famakin BM, Chimowitz MI, Lynn MJ, et al.: Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis. Stroke 2009, 40:1999–2003.CrossRefPubMed

11.

Thijs VN, Lansberg MG, Beaulieu C, et al.: Is early ischemic lesion volume on diffusion-weighted imaging an independent predictor of stroke outcome? A multivariable analysis. Stroke 2000, 31:2597–2602.PubMed

12.

• Turan TN, Maidan L, Cotsonis G, et al.: Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis. Stroke 2009, 40:505–509. Substudy of the WASID trial indicating that failure of antithrombotic therapy is not a risk factor for recurrent stroke due to intracranial stenosis.CrossRefPubMed

13.

Mazighi M, Tanasescu R, Ducrocq X, et al.: Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology 2006, 66:1187–1191.CrossRefPubMed

14.

Clark WM, Barnwell SL, Nesbit G, et al.: Safety and efficacy of percutaneous transluminal angioplasty for intracranial atherosclerotic stenosis. Stroke 1995, 26:1200–1204.PubMed

15.

Higashida RT, Tsai FY, Halbach VV, et al.: Transluminal angioplasty for atherosclerotic disease of the vertebral and basilar arteries. J Neurosurg 1993, 78:192–198.CrossRefPubMed

16.

Marks MP, Wojak JC, Al-Ali F, et al.: Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke 2006, 37:1016–1020.CrossRefPubMed

17.

Cruz-Flores S, Diamond AL: Angioplasty for intracranial artery stenosis. Cochrane Database Syst Rev 2006, 3:CD004133.PubMed

18.

Mazighi M, Yadav JS, Abou-Chebl A: Durability of endovascular therapy for symptomatic intracranial atherosclerosis. Stroke 2008, 39:1766–1769.CrossRefPubMed

19.

Siddiq F, Vazquez G, Memon MZ, et al.: Comparison of primary angioplasty with stent placement for treating symptomatic intracranial atherosclerotic diseases: a multicenter study. Stroke 2008, 39:2505–2510.CrossRefPubMed

20.

SSYLVIA Study Investigators [no authors listed]. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 2004, 35:1388–1392.CrossRef

21.

Bose A, Hartmann M, Henkes H, et al.: A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke 2007, 38:1531–1537.CrossRefPubMed

22.

•• Zaidat OO, Klucznik R, Alexander MJ, et al.: The NIH registry on use of the wingspan stent for symptomatic 70–99% intracranial arterial stenosis. Neurology 2008, 70:1518–1524. NIH-sponsored, multicenter, uncontrolled trial reporting the results of the Wingspan stent in a prospective cohort. CrossRefPubMed

23.

•• Fiorella D, Levy EI, Turk AS, et al.: US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 2007, 38:881–887. Initial publication from the US Wingspan Registry describing periprocedural results. CrossRefPubMed

24.

Albuquerque FC, Levy EI, Turk AS, et al.: Angiographic patterns of Wingspan in-stent restenosis. Neurosurgery 2008, 63:23–27; discussion 27–28.CrossRefPubMed

25.

Levy EI, Turk AS, Albuquerque FC, et al.: Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery 2007, 61:644–650; discussion 650–651.

26.

• Turk AS, Levy EI, Albuquerque FC, et al.: Influence of patient age and stenosis location on Wingspan in-stent restenosis. AJNR Am J Neuroradiol 2008, 29:23–27. Publication from the US Wingspan Registry showing that young patients with anterior circulation stents (particularly in the supraclinoid ICA) may be at elevated risk for restenosis. CrossRefPubMed

27.

Fiorella DJ, Levy EI, Turk AS, et al.: Target lesion revascularization after Wingspan: assessment of safety and durability. Stroke 2009, 40:106–110.CrossRefPubMed

28.

Kallmes DF, Cloft HJ: How do we spin wingspan? AJNR Am J Neuroradiol 2008, 29:28–29.CrossRefPubMed

29.

Turk AS: US Wingspan registry: results at 1 year. Presented at the 10th Congress of the World Federation of Interventional and Therapeutic Neuroradiology. Montreal, Canada; June 29–July 3, 2009.

30.

Jiang WJ, Xu XT, Du B, et al.: Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis. Neurology 2007, 68:420–426.CrossRefPubMed

31.

Lylyk P, Vila JF, Miranda C, et al.: Endovascular reconstruction by means of stent placement in symptomatic intracranial atherosclerotic stenosis. Neurol Res 2005, 27(Suppl 1):S84–S88.CrossRefPubMed

32.

• Groschel K, Schnaudigel S, Pilgram SM, et al.: A systematic review on outcome after stenting for intracranial atherosclerosis. Stroke 2009, 40:e340–e347. Systematic meta-analysis of previously reported cohorts of patients treated with stents for intracranial stenosis. CrossRefPubMed

33.

Trinquart L, Touze E: Pitfalls in meta-analysis of observational studies: lessons from a systematic review of the risks of stenting for intracranial atherosclerosis. Stroke 2009, 40:e586–e587; author reply e590.CrossRefPubMed

34.

Jiang WJ, Xu XT, Jin M, et al.: Apollo stent for symptomatic atherosclerotic intracranial stenosis: study results. AJNR Am J Neuroradiol 2007, 28:830–834.PubMed

35.

Kurre W, Berkefeld J, Sitzer M, et al.: Treatment of symptomatic high-grade intracranial stenoses with the balloon-expandable pharos stent: initial experience. Neuroradiology 2008, 50:701–708.CrossRefPubMed

36.

Gupta R, Al-Ali F, Thomas AJ, et al.: Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke 2006, 37:2562–2566.CrossRefPubMed

37.

Qureshi AI, Kirmani JF, Hussein HM, et al.: Early and intermediate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosis. Neurosurgery 2006, 59:1044–1051; discussion 1051.CrossRefPubMed

38.

Steinfort B, Ng PP, Faulder K, et al.: Midterm outcomes of paclitaxel-eluting stents for the treatment of intracranial posterior circulation stenoses. J Neurosurg 2007, 106:222–225.CrossRefPubMed

39.

Abou-Chebl A, Bashir Q, Yadav JS: Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up. Stroke 2005, 36:e165–e168.CrossRefPubMed

40.

Abou-Chebl A, Krieger DW, Bajzer CT, Yadav JS: Intracranial angioplasty and stenting in the awake patient. J Neuroimaging 2006, 16:216–223.CrossRefPubMed

41.

Rosenman DJ, McDonald FS, Ebbert JO, et al.: Clinical consequences of withholding versus administering renin-angiotensin-aldosterone system antagonists in the preoperative period. J Hosp Med 2008, 3:319–325.CrossRefPubMed

42.

• Nahab F, Lynn MJ, Kasner SE, et al.: Risk factors associated with major cerebrovascular complications after intracranial stenting. Neurology 2009, 72:2014–2019. Substudy of the NIH Wingspan trial demonstrating that posterior circulation location, low-volume center, and stroke as qualifying event may be risk factors for complications from intracranial stenosis. CrossRefPubMed

43.

Finn AV, Kolodgie FD, Virmani R: Correlation between carotid intimal/medial thickness and atherosclerosis. A point of view from pathology. Arterioscler Thromb Vasc Biol 2009 Aug 13 (Epub ahead of print).

44.

Kern R, Steinke W, Daffertshofer M, et al.: Stroke recurrences in patients with symptomatic vs asymptomatic middle cerebral artery disease. Neurology 2005, 65:859–864.CrossRefPubMed

45.

Nahab F, Cotsonis G, Lynn M, et al.: Prevalence and prognosis of coexistent asymptomatic intracranial stenosis. Stroke 2008, 39:1039–1041.CrossRefPubMed

46.

Puetz V, Gahn G, Becker U, et al.: Endovascular therapy of symptomatic intracranial stenosis in patients with impaired regional cerebral blood flow or failure of medical therapy. AJNR Am J Neuroradiol 2008, 29:273–280.CrossRefPubMed

47.

Ecker RD, Levy EI, Sauvageau E, et al.: Current concepts in the management of intracranial atherosclerotic disease. Neurosurgery 2008, 62:1425–1433.PubMed

48.

Meyers PM, Schumacher HC, Higashida RT, et al.: Indications for the performance of intracranial endovascular neurointerventional procedures: a scientific statement from the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation 2009, 119:2235–2249.CrossRefPubMed

49.

•• Chaturvedi S, Turan TN, Lynn MJ, et al.: Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology 2007, 69:2063–2068. Substudy from the WASID trial showing that hypertension is a risk factor for recurrent stroke due to intracranial stenosis (previously, many had argued for allowing permissive hypertension in these patients).CrossRefPubMed

Titel: Indications and Applications of Arterial Stents for Stroke Prevention in Atherosclerotic Intracranial Stenosis
verfasst von: Jeremy D. Fields
Kenneth C. Liu
Stanley L. Barnwell
Wayne M. Clark
Helmi L. Lutsep
Publikationsdatum: 01.01.2010
Verlag: Current Science Inc.
Erschienen in: Current Cardiology Reports / Ausgabe 1/2010
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI: https://doi.org/10.1007/s11886-009-0070-4

Anzeige

Neu im Fachgebiet Kardiologie

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

30.04.2024 Hypertonie Nachrichten

Im Vergleich zu anderen Blutdrucksenkern sind Kalziumantagonisten vom Diyhdropyridin-Typ mit einem erhöhten Risiko für eine Mikroalbuminurie und in Abwesenheit eines RAS-Blockers auch für ein terminales Nierenversagen verbunden.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen